Intensive Care Medicine

, Volume 39, Issue 4, pp 727–733 | Cite as

Effect of a hypertonic balanced ketone solution on plasma, CSF and brain beta-hydroxybutyrate levels and acid–base status

  • Hayden White
  • Balasubramanian Venkatesh
  • Mark Jones
  • Simon Worrall
  • Teong Chuah
  • Jenny Ordonez



Although glucose is the main source of energy for the human brain, ketones play an important role during starvation or injury. The purpose of our study was to investigate the metabolic effects of a novel hypertonic sodium ketone solution in normal animals.


Adult Sprague–Dawley rats (420–570 g) were divided into three groups of five, one control and two study arms. The control group received an intravenous infusion of 3 % NaCl at 5 ml/kg/h. The animals in the two study arms were assigned to receive one of the two formulations of ketone solutions, containing hypertonic saline with 40 and 120 mmol/l beta-hydroxybutyrate, respectively. This was infused for 6 h and then the animal was euthanized and brains removed and frozen.


Both blood and cerebrospinal fluid (CSF) levels of beta-hydroxybutyrate (BHB) demonstrated strong evidence of a change over time (p < 0.0001). There was also strong evidence of a difference between groups (p < 0.0001). Multiple comparisons showed all these means were statistically different (p < 0.05). Measurement of BHB levels in brain tissue found strong evidence of a difference between groups (p < 0.0001) with control: 0.15 mmol/l (0.01), BHB 40: 0.19 mmol/l (0.01), and BHB 120: 0.28 mmol/l (0.01). Multiple comparisons showed all these means were statistically different (p < 0.05). There were no differences over time (p = 0.31) or between groups (p = 0.33) or an interaction between groups and time (p = 0.47) for base excess.


The IV infusions of hypertonic saline/BHB are feasible and lead to increased plasma, CSF and brain levels of BHB without significant acid/base effects.


Ketones Ketone bodies Beta-hydroxybutyrate Hypertonic saline Brain injury Intracranial hypertension 


  1. 1.
    Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr (1967) Brain metabolism during fasting. J Clin Invest 46:1589–1595PubMedCrossRefGoogle Scholar
  2. 2.
    Prins ML (2008) Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 28:1–16PubMedCrossRefGoogle Scholar
  3. 3.
    Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB (1996) Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol 270:E746–E751PubMedGoogle Scholar
  4. 4.
    Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51:241–247PubMedCrossRefGoogle Scholar
  5. 5.
    Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV (1994) Control of glucose utilization in working perfused rat heart. J Biol Chem 269:25502–25514PubMedGoogle Scholar
  6. 6.
    Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A (2002) Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 89:36–43PubMedCrossRefGoogle Scholar
  7. 7.
    Puchowicz MA, Zechel JL, Valerio J, Emancipator DS, Xu K, Pundik S, LaManna JC, Lust WD (2008) Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J Cereb Blood Flow Metab 28:1907–1916PubMedCrossRefGoogle Scholar
  8. 8.
    Gasior M, Rogawski MA, Hartman AL (2006) Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol 17:431–439PubMedCrossRefGoogle Scholar
  9. 9.
    Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S (2004) Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25:311–314PubMedCrossRefGoogle Scholar
  10. 10.
    Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB (1994) Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 14:125–131PubMedCrossRefGoogle Scholar
  11. 11.
    Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR (2001) Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 38:519–527PubMedCrossRefGoogle Scholar
  12. 12.
    Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP (2000) Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 20:1502–1507PubMedCrossRefGoogle Scholar
  13. 13.
    Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP (2001) Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 79:539–544PubMedCrossRefGoogle Scholar
  14. 14.
    Linde R, Hasselbalch SG, Topp S, Paulson OB, Madsen PL (2006) Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat. J Cereb Blood Flow Metab 26:170–180PubMedCrossRefGoogle Scholar
  15. 15.
    Prins ML, Lee SM, Fujima LS, Hovda DA (2004) Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J Neurochem 90:666–672PubMedCrossRefGoogle Scholar
  16. 16.
    Eilig I, Rachinsky M, Artru AA, Alonchin A, Kapuler V, Tarnapolski A, Shapira Y (2001) The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats. Anesth Analg 92:669–675PubMedCrossRefGoogle Scholar
  17. 17.
    Shackford SR (1997) Effect of small-volume resuscitation on intracranial pressure and related cerebral variables. J Trauma 42:S48–S53PubMedCrossRefGoogle Scholar
  18. 18.
    Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291:1350–1357PubMedCrossRefGoogle Scholar
  19. 19.
    Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, Margulies D (2009) Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 75:25–29PubMedGoogle Scholar
  20. 20.
    Ritter AM, Robertson CS, Goodman JC, Contant CF, Grossman RG (1996) Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 13:473–485PubMedCrossRefGoogle Scholar
  21. 21.
    Katayama M, Hiraide A, Sugimoto H, Yoshioka T, Sugimoto T (1994) Effect of ketone bodies on hyperglycemia and lactic acidemia in hemorrhagic stress. JPEN J Parenter Enteral Nutr 18:442–446PubMedCrossRefGoogle Scholar
  22. 22.
    Kammula RG (1976) Metabolism of ketone bodies by ovine brain in vivo. Am J Physiol 231:1490–1494PubMedGoogle Scholar
  23. 23.
    Hawkins RA (1971) Uptake of ketone bodies by rat brain in vivo. Biochem J 121:17PPubMedGoogle Scholar
  24. 24.
    Miles JM, Nissen SL, Rizza RA, Gerich JE, Haymond MW (1983) Failure of infused beta-hydroxybutyrate to decrease proteolysis in man. Diabetes 32:197–205PubMedCrossRefGoogle Scholar
  25. 25.
    Arvidsson S, Haggendal E, Wins o I (1981) Effects on cerebral blood flow of infusion of hyperosmolar saline during cerebral vasodilation in the dog. Acta Anaesthesiol Scand 25:153–157PubMedCrossRefGoogle Scholar
  26. 26.
    Schrock H, Kuschinsky W (1989) Cerebrospinal fluid ionic regulation, cerebral blood flow, and glucose use during chronic metabolic alkalosis. Am J Physiol 257:H1220–H1227PubMedGoogle Scholar
  27. 27.
    Pannier JL, Demeester G, Leusen I (1974) The influence of nonrespiratory alkalosis on cerebral blood flow in cats. Stroke 5:324–329PubMedCrossRefGoogle Scholar
  28. 28.
    Giffard RG, Weiss JH, Choi DW (1992) Extracellular alkalinity exacerbates injury of cultured cortical neurons. Stroke 23:1817–1821PubMedCrossRefGoogle Scholar
  29. 29.
    Bourdeaux CP, Brown JM (2011) Randomized controlled trial comparing the effect of 8.4% sodium bicarbonate and 5% sodium chloride on raised intracranial pressure after traumatic brain injury. Neurocrit Care 15:42–45PubMedCrossRefGoogle Scholar
  30. 30.
    Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU (2011) Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 39:554–559PubMedCrossRefGoogle Scholar
  31. 31.
    Cottenceau V, Masson F, Mahamid E, Petit L, Shik V, Sztark F, Zaaroor M, Soustiel JF (2011) Comparison of effects of equiosmolar doses of mannitol and hypertonic saline on cerebral blood flow and metabolism in traumatic brain injury. J Neurotrauma 28:2003–2012PubMedCrossRefGoogle Scholar
  32. 32.
    Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT (2005) Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 57:727–736 discussion 727–736PubMedCrossRefGoogle Scholar
  33. 33.
    White H, Venkatesh B (2011) Clinical review: ketones and brain injury. Crit Care 15:219PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2012

Authors and Affiliations

  • Hayden White
    • 1
  • Balasubramanian Venkatesh
    • 2
  • Mark Jones
    • 3
  • Simon Worrall
    • 4
  • Teong Chuah
    • 5
  • Jenny Ordonez
    • 6
  1. 1.Department of Intensive Care Griffiths UniversityBrisbaneAustralia
  2. 2.Critical Care MedicineUniversity of QueenslandSt LuciaAustralia
  3. 3.University of QueenslandSt LuciaAustralia
  4. 4.Faculty of ScienceUniversity of QueenslandSt LuciaAustralia
  5. 5.Department of SurgeryUniversity of QueenslandSt LuciaAustralia
  6. 6.Therapeutic Research CentreUniversity of QueenslandSt LuciaAustralia

Personalised recommendations